Search

everythinglearnresearchcommunity

for

Search:↓

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Acne affects most teenagers and can continue into adulthood, with various treatments available that show improvement but have concerns like antibiotic resistance and side effects.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Androgens can both increase and decrease hair growth in different parts of the body.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Estrogen therapy can reduce skin aging but has cancer risks.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Lowering testosterone speeds up wound healing in male mice.